Clinical Trial Update: Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating a triplet of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for relapsed B-cell acute lymphoblastic leukemia and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Inotuzumab ozogamicin (inotuzumab ozogamicin)
• Venetoclax (venetoclax)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING